BL Pharmtech Corp. (KOSDAQ: 065170)

BL Pharmtech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 15, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	19,128	44,929	55,605	116,549	145,716	87,904
Market Cap Growth	-16.17%	-19.20%	-52.29%	-20.02%	65.77%	-7.61%
Enterprise Value	19,785	86,785	100,284	144,445	185,313	79,894
Last Close Price	215.00	505.00	625.00	1310.00	1675.00	1420.00
PS Ratio	1.15	1.83	2.47	1.38	2.22	1.49
PB Ratio	0.63	1.41	1.35	1.78	2.00	1.73
P/TBV Ratio	1.74	1.46	2.26	2.66	4.13	2.24
P/FCF Ratio	-	5.85	-	46.44	-	-
P/OCF Ratio	69.06	5.62	-	37.64	25.11	24.25
EV/Sales Ratio	1.18	3.54	4.45	1.71	2.82	1.36
EV/EBITDA Ratio	-	-	-	-	394.74	-
EV/FCF Ratio	-100.36	11.30	-	57.56	-	-
Debt / Equity Ratio	0.17	0.13	1.04	0.64	0.60	0.56
Debt / EBITDA Ratio	-	-	-	-	93.61	-
Debt / FCF Ratio	-	0.55	-	16.69	-	-
Asset Turnover	0.24	0.33	0.19	0.64	0.59	0.61
Inventory Turnover	1.03	1.32	0.87	6.68	5.12	4.64
Quick Ratio	0.88	1.79	0.34	0.90	0.71	1.97
Current Ratio	1.13	2.12	0.67	1.14	1.09	2.42
Return on Equity (ROE)	-30.72%	-37.90%	-27.09%	-29.05%	-26.79%	-28.36%
Return on Assets (ROA)	-5.15%	-5.99%	-2.56%	-1.70%	-1.15%	-5.24%
Return on Capital (ROIC)	-6.45%	-7.43%	-3.13%	-2.00%	-1.31%	-5.83%
Earnings Yield	16.70%	-0.33%	-25.00%	-17.34%	-12.32%	-13.45%
FCF Yield	-1.03%	17.09%	-22.85%	2.15%	-8.11%	-22.57%
Buyback Yield / Dilution	-0.50%	-	-1.33%	-18.44%	-19.95%	-9.75%
Total Shareholder Return	-0.50%	-	-1.33%	-18.44%	-19.95%	-9.75%

Source: S&P Capital IQ. Standard template. Financial Sources.